DrugPatentWatch Database Preview

Sun Pharm Inds Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?

SUN PHARM INDS LTD has one hundred and seventeen approved drugs.

There are eight US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.

There are thirty-one patent family members on SUN PHARM INDS LTD drugs in nineteen countries and one hundred and thirty-eight supplementary protection certificates in thirteen countries.

Summary for Sun Pharm Inds Ltd

International Patents:	31
US Patents:	8
Tradenames:	90
Ingredients:	87
NDAs:	117

Drugs and US Patents for Sun Pharm Inds Ltd

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Ltd	AMOXICILLIN	amoxicillin	FOR SUSPENSION;ORAL	065113-002	Nov 29, 2002		DISCN	No	No
Sun Pharm Inds Ltd	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076607-002	Dec 15, 2004		DISCN	No	No
Sun Pharm Inds Ltd	CIPROFLOXACIN HYDROCHLORIDE	ciprofloxacin hydrochloride	TABLET;ORAL	075747-003	Jun 9, 2004		DISCN	No	No
Sun Pharm Inds Ltd	ENALAPRIL MALEATE	enalapril maleate	TABLET;ORAL	075556-003	Aug 22, 2000		DISCN	No	No

Expired US Patents for Sun Pharm Inds Ltd

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Inds Ltd	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-005	Jul 11, 2012	5,908,838
Sun Pharm Inds Ltd	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-001	Jul 11, 2012	5,908,838
Sun Pharm Inds Ltd	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-003	Jul 11, 2012	5,908,838

Non-Orange Book US Patents for Sun Pharm Inds Ltd

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,559,187	Liquid formulation of metformin
9,192,615	Method for the treatment of acne and certain dosage forms thereof
8,722,650	Extended-release minocycline dosage forms

International Patents for Sun Pharm Inds Ltd Drugs

Country	Document Number	Estimated Expiration
New Zealand	564093
Canada	2613273
Hungary	0302700
Canada	2416767

Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
30/2006	Austria		PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SÄUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN
2008013	Lithuania		PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REG. NO/DATE: EU/1/08/455/001-014 20080716
C0021	Belgium		PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
1998	Austria		PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Sun Pharm Inds
• Sun Pharm Inds (in)
• Sun Pharm Inds Inc
• Sun Pharm Inds Ltd